As those watching the resource space are no doubt aware, the first six months of 2014 saw quite a few junior miners make forays into the medical marijuana sector.

Encouragingly for those companies, swathes of investors have been only too eager to follow. However, many analysts believe that’s a problem, in part because the sector is so new, but also because there’s still so much bureaucratic red tape and uncertainty surrounding marijuana use, even for medical purposes.

It’s thus unsurprising that “caution” and “profit” were the words of the hour at Monday’s Canadian Investor Conference marijuana panel, which featured activist Jodie Emery, Daniel Kiselbach of Deloitte Tax Law, Midas Letter’s James West and Paul Pelosi, Jr. of Verde Science (OTCMKTS:VRCI).

Why be cautious?

Giving his take on the need for caution, West explained that, at least in Canada, there’s a disconnect between what licensed commercial growers think they can achieve and what is actually achievable. Specifically, he said, those growers “predict that they will realize a price of $8 per gram” when “probably 25,000” of the 38,000 medical marijuana users registered with Health Canada “have been on disability and paying less than $1 a gram from compassionate growers and suppliers.”

While that could be a “great opportunit[y]” for traders able to ride stocks up as they’re buoyed by marijuana-related plans, it also means that ultimately there will be a “very slow and consistent degradation for the sector as a whole” as companies that don’t follow through on those plans disappear.

On a similar note, Emery pointed out that companies hoping to grow marijuana “are being promised a marketplace that … does exist,” but is already being served. In her opinion, it will thus be tough for companies to make the money they’ve been promised unless the market expands via “legalization for all” or unless they can “offer something that people can’t get elsewhere.”

Kiselbach was a little more positive, pointing to Tweed Marijuana’s (TSXV:TWD) success after listing on the TSX Venture Exchange and commenting, “there are opportunities, at least at this point in time, for making money.” However, he said, companies must do “careful planning in order to be profitable,” and unfortunately many are not making an effort to do so.

Profitable opportunities

Those comments may sound daunting, but none of the panelists denied that profiting from medical marijuana is indeed possible. Here’s what they said when asked which companies they think are “doing it right.”

  • West: “The best-looking business plan I’ve seen yet belongs to a company called THC Bank, which focuses on protecting and preserving the genetic integrity of various strains of marijuana for growers.”
  • Kiselbach: Kiselbach again identified Tweed as a company that is making money.
  • Emery: Though she noted that she wasn’t there to offer stock picks, Emery did point to her own success at working “in the marijuana industry without actually dealing with marijuana itself.” She also emphasized the importance of supporting companies that advocate for full legalization.
  • Pelosi: “Investors do flock to corporations which have strong corporate governance,” said Pelosi. Additionally, he noted that corporate mission is important, as is growth potential for revenue, a quality he believes Verde Science certainly has.

Certainly some food for thought for investors watching the sector.

Stay tuned for a video interview with Jodie Emery. 


Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article. 

Related reading: 

Investing in Marijuana: A High-risk Green Rush

Making the Switch: 3 Junior Mining CEOs Explain the Pull of Medical Marijuana

Deloitte Tax Law: What to Look for in a Medical Marijuana Company

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less